Title |
Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
|
---|---|
Published in |
Frontiers in immunology, March 2016
|
DOI | 10.3389/fimmu.2016.00118 |
Pubmed ID | |
Authors |
Martin Szyska, Il-Kang Na |
Abstract |
The bone marrow is the origin of all hematopoietic lineages and an important homing site for memory cells of the adaptive immune system. It has recently emerged as a graft-versus-host disease (GvHD) target organ after allogeneic stem cell transplantation (alloHSCT), marked by depletion of both hematopoietic progenitors and niche-forming cells. Serious effects on the restoration of hematopoietic function and immunological memory are common, especially in patients after myeloablative conditioning therapy. Cytopenia and durable immunodeficiency caused by the depletion of hematopoietic progenitors and destruction of bone marrow niches negatively influence the outcome of alloHSCT. The complex balance between immunosuppressive and cell-depleting treatments, GvHD and immune reconstitution, as well as the desirable graft-versus-tumor (GvT) effect remains a great challenge for clinicians. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 4 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Science communicators (journalists, bloggers, editors) | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 83 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 14% |
Researcher | 11 | 13% |
Student > Bachelor | 10 | 12% |
Student > Doctoral Student | 9 | 11% |
Student > Master | 8 | 10% |
Other | 14 | 17% |
Unknown | 19 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 24% |
Agricultural and Biological Sciences | 13 | 16% |
Biochemistry, Genetics and Molecular Biology | 10 | 12% |
Immunology and Microbiology | 10 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Other | 7 | 8% |
Unknown | 19 | 23% |